Adents will showcase scalable solutions at Interpack, the world's largest packaging trade fair in Dusseldorf, Germany
Adents, provider serialisation and track and trace software, will showcase its latest solutions to secure the pharmaceutical supply chain from May 4–10 at Interpack.
Located at Hall 6, Booth D10, Adents will showcase its two primary products, Adents Seriza and Adents Prodigi, each of which enable marketing authorisation holders (MAHs) and contract manufacturers (CMOs) to comply with laws and regulations on drug traceability.
Adents has been supported worldwide by a steadily growing collection of about 300 certified solution partners and qualified mechanical engineers.
The company’s co-founder and CEO, Christophe Devins, has more than 25 years of experience in unit-level product identification and traceability and has overseen the outfitting of more than 2,000 packaging lines with serialisation solutions.
“Our solutions for pharmaceutical packaging are primarily designed to meet regulatory requirements,” said Devins.
Devins has participated in several international pharmaceutical congresses, and regularly lends his expertise to industry working groups and meetings toward the establishment of globally standardised serialisation communication.
Adent software is hardware agnostic and therefore compatible with existing devices. As a standardised solution, it can be configured on a new line or at multiple production facilities.
This has allowed its collaboration with global engineering and technology services company Siemens, to integrate the configurable software suite into the full range of standard hardware.
“Pharma companies will have a multitude of complex issues to take into account when choosing a serialisation solution: budget control; risk of productivity drops; variety of industrial equipment; and tight implementation planning,” said Hans Bijl, of Siemens (Business Development, Life Science).
Adents Seriza maintains comparably high levels of Overall Equipment Efficiency (OEE) for continued high-capacity production.
This is particularly important in view of the approaching deadline for binding compliance with the EU Anti-Counterfeiting Directive (2011/62 / EU) in 2019.